Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results matching your filters

STOP-PKD: SGLT2-inhibition to Improve Prognosis in Polycystic Kidney DiseaseRecruiting
NCT07280585Phase 3Updated Jul 28, 2026
Sponsor: University of Cologne
Polycystic Kidney, Autosomal Dominant
Austria, Germany, Netherlands, Spain
A Study to Assess the Effectiveness and Safety of IPN10200 in Adults With Moderate to Severe Wrinkle-like Lines Between the EyebrowsRecruiting
NCT07427797Phase 3Updated Jul 28, 2026
Sponsor: Ipsen
Moderate to Severe Glabellar Lines
United States, Canada
A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to Severe Wrinkle-like Lines Between the EyebrowsRecruiting
NCT07435428Phase 3Updated Jul 28, 2026
Sponsor: Ipsen
Moderate to Severe Glabellar Lines
United States, France, Germany, Japan
Study of ALK-001 on the Progression of Stargardt DiseaseRecruiting
NCT07419334Phase 3Updated Jul 28, 2026
Sponsor: Alkeus Pharmaceuticals, Inc.
Stargardt Disease
United States
A Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria, Tetanus and Acellular Pertussis (dTpa) in Japanese Healthy Pregnant WomenRecruiting
NCT07596199Phase 3Updated Jul 28, 2026
Sponsor: GlaxoSmithKline
Diphtheria-Tetanus-acellular Pertussis Vaccines
Japan
A Study of Lisaftoclax (APG-2575) Combined With Acalabrutinib Versus Immunochemotherapy for Newly Diagnosed CLL/SLL.Recruiting
NCT06319456Phase 3Updated Jul 28, 2026
Sponsor: Ascentage Pharma Group Inc.
CLL/SLL
China
Influenza Vaccination Strategy for Patients With Hematologic MalignancyRecruiting
NCT07485855Phase 3Updated Jul 28, 2026
Sponsor: Asan Medical Center
Hematologic Neoplasms · Influenza · Immunogenicity
South Korea
A Study to Test the Effects and Safety of Palopegteriparatide in Adolescents With Long-term HypoparathyroidismRecruiting
NCT07706764Phase 3Updated Jul 28, 2026
Sponsor: Ascendis Pharma A/S
Hypoparathyroidism
France, Poland
Rifampin-free Regimen Versus Rifampin-containing Regimen in the Treatment of Staphylococcal Prosthetic Valve EndocarditisRecruiting
NCT07345325Phase 3Updated Jul 28, 2026
Sponsor: Nantes University Hospital
Infective Endocarditis
France
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood PressureRecruiting
NCT06742723Phase 3Updated Jul 28, 2026
Sponsor: AstraZeneca
Chronic Kidney Disease and Hypertension
United States, Argentina, Australia, Belgium, Brazil +37 more
Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic MedicationsRecruiting
NCT07565428Phase 3Updated Jul 28, 2026
Sponsor: Minerva Neurosciences
Negative Symptoms of Schizophrenia
United States
Effect of Ketosteril on Sarcopenia in Patients With Chronic Kidney DiseaseRecruiting
NCT06329622Phase 3Updated Jul 28, 2026
Sponsor: Huashan Hospital
Chronic Kidney Disease · Sarcopenia
China
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)Recruiting
NCT04928846Phase 3Updated Jul 28, 2026
Sponsor: AbbVie
Non Small Cell Lung Cancer
United States, Argentina, Australia, Austria, Belgium +27 more
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube CancerRecruiting
NCT06161025Phase 2, Phase 3Updated Jul 28, 2026
Sponsor: Daiichi Sankyo
Solid Cancer
United States, Australia, Brazil, Canada, China +14 more
BEACON - Phase III Clinical Study of Rugonersen in Angelman Syndrome.Recruiting
NCT07605429Phase 3Updated Jul 28, 2026
Sponsor: OHB Pediatrics Ltd.
Angelman Syndrome
United States
A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat CancerRecruiting
NCT06563479Phase 3Updated Jul 28, 2026
Sponsor: Memorial Sloan Kettering Cancer Center
HPV-Related Squamous Cell Carcinoma
United States
A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic AcidosisRecruiting
NCT07355062Phase 3Updated Jul 28, 2026
Sponsor: Renibus Therapeutics, Inc.
CKD · Metabolic Acidosis
United States
Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using SolriamfetolRecruiting
NCT06413433Phase 3Updated Jul 28, 2026
Sponsor: Axsome Therapeutics, Inc.
Binge-Eating Disorder
United States
Suzetrigine Frame Trial Comparing Suzetrigine and AcetaminophenRecruiting
NCT07525219Phase 3Updated Jul 28, 2026
Sponsor: Wake Forest University Health Sciences
Analgesic Efficacy
United States
Acute Sodium Bicarbonate Supplementation in Female Basketball PlayersRecruiting
NCT07730606Phase 3Updated Jul 28, 2026
Sponsor: Krzysztof Durkalec-Michalski
Supplementation · Sports
Poland
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial CancerRecruiting
NCT07022483Phase 3Updated Jul 28, 2026
Sponsor: Daiichi Sankyo
Endometrial Cancer
United States, Argentina, Chile, China, France +8 more
Phase III Clinical Study of VC004 in Patients With Localized Advanced/ Metastatic Solid TumorsRecruiting
NCT06658353Phase 3Updated Jul 27, 2026
Sponsor: Jiangsu vcare pharmaceutical technology co., LTD
Locally Advanced Solid Tumor
China
A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHDRecruiting
NCT07038200Phase 3Updated Jul 27, 2026
Sponsor: Avidity Biosciences, Inc.
Facioscapulohumeral Muscular Dystrophy · FSHD · FSHD - Facioscapulohumeral Muscular Dystrophy · FSHD1
United States, Canada, Denmark, France, Germany +5 more
Platform Trial For Cryptococcal Meningitis (PLATFORM-CM)Recruiting
NCT06666322Phase 2, Phase 3Updated Jul 27, 2026
Sponsor: David Boulware
Hiv · Cryptococcal Meningitis
Uganda
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast CancerRecruiting
NCT05894239Phase 3Updated Jul 27, 2026
Sponsor: Hoffmann-La Roche
Metastatic Breast Cancer
United States, Argentina, Australia, Belgium, Brazil +24 more

Previous page Next page